Your browser doesn't support javascript.
loading
Phosphorylation of nuclear receptors: Novelty and therapeutic implications.
Shindo, Sawako; Kakizaki, Satoru; Sakaki, Toshiyuki; Kawasaki, Yuki; Sakuma, Tsutomu; Negishi, Masahiko; Shizu, Ryota.
Affiliation
  • Shindo S; Department of Environmental Toxicology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.
  • Kakizaki S; Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, 36 Takamatsu-cho, Takasaki, Gunma 370-0829, Japan.
  • Sakaki T; Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan.
  • Kawasaki Y; Laboratory of Public Health, Faculty of Pharmacy, Takasaki University of Health and Welfare, 60 Nakaourui-machi, Takasaki, Gunma 370-0033, Japan.
  • Sakuma T; School of Pharmaceutical Sciences, Ohu University, Koriyama, Fukushima 963-8611, Japan.
  • Negishi M; Reproductive and Developmental Biology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA. Electronic address: negishi@niehs.nih.gov.
  • Shizu R; Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan. Electronic address: r_shizu@u-shizuoka-ken.ac.jp.
Pharmacol Ther ; 248: 108477, 2023 08.
Article in En | MEDLINE | ID: mdl-37330113

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Cytoplasmic and Nuclear / DNA-Binding Proteins Limits: Humans Language: En Journal: Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Cytoplasmic and Nuclear / DNA-Binding Proteins Limits: Humans Language: En Journal: Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido